Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
5.28
-0.07 (-1.31%)
At close: Jun 18, 2026, 4:00 PM EDT
5.36
+0.08 (1.52%)
After-hours: Jun 18, 2026, 6:54 PM EDT
Aligos Therapeutics Market Cap
Aligos Therapeutics has a market cap or net worth of $32.67 million as of June 18, 2026. Its market cap has decreased by -15.05% in one year.
Market Cap
32.67M
Enterprise Value
-17.88M
1-Year Change
-15.05%
Ranking
Category
Stock Price
$5.28
Market Cap Chart
Since the IPO on October 16, 2020, Aligos Therapeutics's market cap has decreased from $553.35M to $32.67M, a decrease of -94.10%. That is a compound annual growth rate of -39.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 32.67M | -43.03% |
| Dec 31, 2025 | 57.35M | -61.21% |
| Dec 31, 2024 | 147.87M | 197.20% |
| Dec 29, 2023 | 49.75M | 21.95% |
| Dec 30, 2022 | 40.80M | -91.93% |
| Dec 31, 2021 | 505.85M | -52.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grace Therapeutics | 36.83M |
| GridAI Technologies | 35.93M |
| Nutriband | 35.25M |
| ABVC BioPharma | 34.11M |
| Daré Bioscience | 32.51M |
| Actinium Pharmaceuticals | 32.32M |
| Boundless Bio | 32.12M |
| Lisata Therapeutics | 32.05M |